Akoya to Participate at Three Upcoming Investor Conferences
2023年7月27日 - 5:05AM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced that Company management will be
participating in three upcoming investor conferences.
- Canaccord
43rd Annual Growth
ConferenceFireside Chat on Wednesday, August 9th at 9:00
AM ET
- UBS MedTech, Tools &
Genomics SummitFireside Chat on Thursday, August 17th at
3:00 PM PT
- Morgan Stanley
21st Annual Global Healthcare
ConferenceFireside Chat on Wednesday, September 13th at
10:10 AM ET
A live and archived webcast of the events will be available on
the “Investors” section of the Akoya website at
https://investors.akoyabio.com/.
About Akoya BiosciencesAs The Spatial Biology
Company®, Akoya Biosciences’ mission is to bring context to the
world of biology and human health through the power of spatial
phenotyping. The company offers comprehensive single-cell imaging
solutions that allow researchers to phenotype cells with spatial
context and visualize how they organize and interact to influence
disease progression and response to therapy. Akoya offers a full
continuum of spatial phenotyping solutions to serve the diverse
needs of researchers across discovery, translational and clinical
research via its key platforms: PhenoCycler™, PhenoImager™ Fusion
and PhenoImager HT. To learn more about Akoya,
visit http://www.akoyabio.com.
Investor Contact:Priyam ShahSr. Director,
Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com
Media Contact:Christine Quern(617)
650-8497media@akoyabio.com
Akoya BioSciences (NASDAQ:AKYA)
過去 株価チャート
から 4 2024 まで 5 2024
Akoya BioSciences (NASDAQ:AKYA)
過去 株価チャート
から 5 2023 まで 5 2024